408 related articles for article (PubMed ID: 31096982)
1. Prevalence and management of chronic breathlessness in COPD in a tertiary care center.
Carette H; Zysman M; Morelot-Panzini C; Perrin J; Gomez E; Guillaumot A; Burgel PR; Deslee G; Surpas P; Le Rouzic O; Perez T; Chaouat A; Roche N; Chabot F;
BMC Pulm Med; 2019 May; 19(1):95. PubMed ID: 31096982
[TBL] [Abstract][Full Text] [Related]
2. Junior doctors' attitudes to opioids for refractory breathlessness in patients with advanced chronic obstructive pulmonary disease.
Smallwood N; Gaffney N; Gorelik A; Irving L; Le B; Philip J
Intern Med J; 2017 Sep; 47(9):1050-1056. PubMed ID: 28585274
[TBL] [Abstract][Full Text] [Related]
3. Differing Approaches to Managing the Chronic Breathlessness Syndrome in Advanced COPD: A Multi-National Survey of Specialists.
Smallwood N; Currow D; Booth S; Spathis A; Irving L; Philip J
COPD; 2018 Jun; 15(3):294-302. PubMed ID: 30204492
[TBL] [Abstract][Full Text] [Related]
4. Management of COPD in End-of-Life Care by Spanish Pulmonologists.
Ecenarro PS; Iguiñiz MI; Tejada SP; Malanda NM; Imizcoz MA; Marlasca LA; Navarrete BA
COPD; 2018 Apr; 15(2):171-176. PubMed ID: 29558226
[TBL] [Abstract][Full Text] [Related]
5. Prescription of opioids for breathlessness in end-stage COPD: a national population-based study.
Ahmadi Z; Bernelid E; Currow DC; Ekström M
Int J Chron Obstruct Pulmon Dis; 2016; 11():2651-2657. PubMed ID: 27799763
[TBL] [Abstract][Full Text] [Related]
6. Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status: A Randomized Clinical Trial.
Verberkt CA; van den Beuken-van Everdingen MHJ; Schols JMGA; Hameleers N; Wouters EFM; Janssen DJA
JAMA Intern Med; 2020 Oct; 180(10):1306-1314. PubMed ID: 32804188
[TBL] [Abstract][Full Text] [Related]
7. Attitudes toward opioids for refractory dyspnea in COPD among Dutch chest physicians.
Janssen DJ; de Hosson SM; bij de Vaate E; Mooren KJ; Baas AA
Chron Respir Dis; 2015 May; 12(2):85-92. PubMed ID: 25676931
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological management of breathlessness in COPD: recent advances and hopes for the future.
O'Donnell DE; Webb KA; Harle I; Neder JA
Expert Rev Respir Med; 2016 Jul; 10(7):823-34. PubMed ID: 27115291
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and burden of breathlessness in patients with chronic obstructive pulmonary disease managed in primary care.
Müllerová H; Lu C; Li H; Tabberer M
PLoS One; 2014; 9(1):e85540. PubMed ID: 24427316
[TBL] [Abstract][Full Text] [Related]
10. Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review.
Ekström M; Nilsson F; Abernethy AA; Currow DC
Ann Am Thorac Soc; 2015 Jul; 12(7):1079-92. PubMed ID: 25803110
[TBL] [Abstract][Full Text] [Related]
11. Barriers to Prescribing Opioids in the Management of Chronic Breathlessness in COPD: A Review.
Keogh E; Williams EM
COPD; 2021 Dec; 18(6):713-722. PubMed ID: 34761726
[TBL] [Abstract][Full Text] [Related]
12. Management of refractory breathlessness with morphine in patients with chronic obstructive pulmonary disease.
Smallwood N; Le B; Currow D; Irving L; Philip J
Intern Med J; 2015 Sep; 45(9):898-904. PubMed ID: 26332621
[TBL] [Abstract][Full Text] [Related]
13. Breathlessness, functional status, distress, and palliative care needs over time in patients with advanced chronic obstructive pulmonary disease or lung cancer: a cohort study.
Weingaertner V; Scheve C; Gerdes V; Schwarz-Eywill M; Prenzel R; Bausewein C; Higginson IJ; Voltz R; Herich L; Simon ST; ;
J Pain Symptom Manage; 2014 Oct; 48(4):569-81.e1. PubMed ID: 24613784
[TBL] [Abstract][Full Text] [Related]
14. Chronic breathlessness in advanced cardiorespiratory disease: patient perceptions of opioid use.
Moran T; Zentner D; Wong J; Philip J; Smallwood N
BMJ Support Palliat Care; 2023 Dec; 13(e2):e334-e343. PubMed ID: 33837113
[TBL] [Abstract][Full Text] [Related]
15. Persistent disabling breathlessness in chronic obstructive pulmonary disease.
Sundh J; Ekström M
Int J Chron Obstruct Pulmon Dis; 2016; 11():2805-2812. PubMed ID: 27877034
[TBL] [Abstract][Full Text] [Related]
16. Individualized breathlessness interventions may improve outcomes in patients with advanced COPD.
Qian MYY; Politis J; Thompson M; Wong D; Le B; Irving L; Smallwood N
Respirology; 2018 Dec; 23(12):1146-1151. PubMed ID: 29763515
[TBL] [Abstract][Full Text] [Related]
17. Anxiety and depression among dairy farmers: the impact of COPD.
Guillien A; Laurent L; Soumagne T; Puyraveau M; Laplante JJ; Andujar P; Annesi-Maesano I; Roche N; Degano B; Dalphin JC
Int J Chron Obstruct Pulmon Dis; 2018; 13():1-9. PubMed ID: 29296078
[TBL] [Abstract][Full Text] [Related]
18. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
[TBL] [Abstract][Full Text] [Related]
19. Comparative study on health care utilization and hospital outcomes of severe acute exacerbation of chronic obstructive pulmonary disease managed by pulmonologists vs internists.
Pothirat C; Liwsrisakun C; Bumroongkit C; Deesomchok A; Theerakittikul T; Limsukon A
Int J Chron Obstruct Pulmon Dis; 2015; 10():759-66. PubMed ID: 25926727
[TBL] [Abstract][Full Text] [Related]
20. Managing Severe Chronic Breathlessness in Chronic Obstructive Pulmonary Disease Is Challenging for General Practitioners.
Politis J; Eastman P; Le B; Furler J; Irving L; Smallwood N
Am J Hosp Palliat Care; 2021 May; 38(5):472-479. PubMed ID: 32940530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
